AiM Medical Robotics (AiM) has signed an agreement with Siemens Healthineers to develop an interface that will allow AiM\u2019s robotic neurosurgery platform to integrate with Siemens Healthineers\u2019 magnetic resonance imaging (MRI) systems.<\/p>\n
The collaboration focuses on connecting AiM\u2019s MRI-compatible robotic stereotactic neurosurgery system with Siemens Healthineers\u2019 range of MAGNETOM MRI scanners.<\/p>\n
The new software interface is intended to enable data exchange and collaborative operation between the two technologies.<\/p>\n
The integration will apply to Siemens Healthineers\u2019 1.5T, 3T, and 0.55T MRI systems, including the MAGNETOM Free.XL.<\/p>\n
AiM stated that this interface is designed to facilitate real-time, in-bore neurosurgical procedures.<\/p>\n
It supports precision image-guided therapies during interventions such as neurostimulator lead placement, tumour and epilepsy ablation, biopsies, and therapeutic delivery.<\/p>\n
AiM founder and CEO Gregory Fischer said: \u201cThe opportunity to collaborate with a global technology leader like Siemens Healthineers further validates AiM\u2019s technology and expands the ecosystem needed to bring next-generation precision robotics to image-guided operating suites worldwide.<\/p>\n
\u201cThis collaboration accelerates our roadmap toward clinical deployment and reinforces AiM\u2019s mission to make MRI-guided neurosurgery faster, safer, and more accessible.\u201d<\/p>\n
Siemens Healthineers indicated that it will continue to explore expanded software synchronisation and compatibility with AiM\u2019s robotic platform under its third-party collaboration framework.<\/p>\n
AiM specialises in developing MRI-compatible robotic platforms for neurosurgery, with its initial product focusing on enabling accurate, MRI-guided interventions.<\/p>\n
The interface agreement marks a step towards enabling coordinated operation between robotics and imaging systems for neurosurgical procedures.<\/p>\n
In May 2024, AiM Medical Robotics partnered with<\/a> Harvard Medical School\u2019s affiliate Brigham and Women\u2019s Hospital in the US to conduct a study validating its robot for deep-brain stimulation in patients with Parkinson\u2019s disease.<\/p>\n